期刊文献+

骨髓增生异常综合征铁过载的研究进展 被引量:1

原文传递
导出
摘要 大部分骨髓增生异常综合征(MDS)患者在诊断时即存在贫血并呈进行性加重,最终发展为输血依赖。MDS患者发生铁过载的原因主要是输血依赖和无效造血。铁过载可显著降低MDS患者的预期寿命,并增加其向急性髓系白血病(AML)转化的风险。去铁治疗可显著改善MDS患者的预后,延长其生存期并降低其向白血病转化的风险。本文就MDS患者铁过载的原因及铁过载对MDS预后的影响等方面进行阐述。
作者 徐萍 赵明峰
出处 《中华医学杂志》 CAS CSCD 北大核心 2016年第26期2115-2117,共3页 National Medical Journal of China
基金 国家自然科学基金(81400092) 天津市自然科学基金(13JCYBJC23400) 天津市卫生局科技基金攻关项目(13KG106)
  • 相关文献

参考文献2

二级参考文献13

  • 1Kim A, Nemeth E. New insights into iron regulation and erythropoiesis[ J]. Curr Opin Hematol, 2015, 22 (3) : 199-205. DOI : 10. 1097/MOH. 0000000000000132.
  • 2Suragani RN, Cadena SM, Cawley SM, et al. Transforming growth factor-13 superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis [ J ]. Nat Med, 2014, 20 (4) :408-414. DOI:10. 1038/nm. 3512.
  • 3Dussiot M, Maciel TY, Fricot A, et al. An activin receptor Ⅱ A ligand trap corrects ineffective erythropoiesis in 13-thalassemia[ J 3. Nat Med, 2014, 20(4) :398-407. DOI:10. 1038/nm. 3468.
  • 4Carrancio S, Markovies J, Wong P, et aL An activin receptor II A ligand trap promotes erythropoiesis resulting in a rapid induction of red blood cells and haemoglobin[ J]. Br J Haematol, 2014, 165 (6) :870-882. DOI:10.11 ll/bjh. 12838.
  • 5Platzbecker U, Germing U, Giagounidis A, et al. ACE-536 increases hemoglobin and reduces transfusion burden in patients with low or intermediate-1 risk myelodysplastic syndromes (MDS): preliminary results from a phase 2 study [ C/OL]// American Society of Hematology Annual Meeting. San Francisco: blood, 2014 : 411 [ 2014-12-05 3. http ://www. bloodjournal, org/ content/124/21/411.
  • 6Komrokjl RS, Garcia-Manero G, Ades L, et al. An open-label, phase 2, dose-finding study of sotatercept ( ACE-011 ) in patients with low or intermediate-1 ( int-1 ) -risk myelodysplastic syndromes (MDS) or non-proliferative chronic myalomonocytic leukemia (CMML) and anemia requiring transfusion [ C/OL ]//American Society of Hematology Annual Meeting. San Francisco: blood, 2014:3251 [ 2014-12-07 ]. http://www, bloodjoumal, org/ content/124/21/3251.
  • 7Katsimpardi L, Litterman NK, Schein PA, et al. Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors [ J ]. Science, 2014, 344 ( 6184 ) : 630-634. DOI: 10.1126/science. 1251141.
  • 8Sinha M, Jang YC, Oh J, et al. Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle [ J ]. Science, 2014, 344 ( 6184 ) : 649-652. DOI: 10. 1126/science. 1251152.
  • 9Laviano A. Young bloodl [J]. N Engl J Med, 2014, 371(6) :573- 575. DOI:10. 1056/NE]Mcihr1407158.
  • 10Hall SS. Young blood[ J ]. Science, 2014, 345 ( 6202 ) : 1234- 1237. DOI : 10. l126/seienee. 345. 6202. 1234.

共引文献8

同被引文献2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部